Initiating Early Control of Migraine Pain and Associated Symptoms
Public ClinicalTrials.gov record NCT04163185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Single-dose, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
AXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in adults. AXS-07 tablets are formulated to provide an enhanced rate of absorption of meloxicam. This study is designed to evaluate the efficacy and safety of AXS-07 compared to placebo. This is a randomized, double-blind, single-dose, placebo-controlled trial. Subjects who successfully complete the screening period and continue to meet all entry criteria will be randomly assigned to take one dose of either AXS-07 or placebo upon the earliest onset of migraine pain.
Study identification
- NCT ID
- NCT04163185
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 302 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 8, 2019 (Actual)
- Primary completion
- Mar 16, 2020 (Actual)
- Completion
- Mar 23, 2020 (Actual)
- Last update posted
- Jan 28, 2026
2019 – 2020
United States locations
- U.S. sites
- 41
- U.S. states
- 19
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Site | Birmingham | Alabama | 35205 | — |
| Clinical Research Site | Birmingham | Alabama | 35216 | — |
| Clinical Research Site | Mobile | Alabama | 36608 | — |
| Clinical Research Site | Colton | California | 92399 | — |
| Clinical Research Site | Encino | California | 91316 | — |
| Clinical Research Site | Los Alamitos | California | 90720 | — |
| Clinical Research Site | Los Angeles | California | 90017 | — |
| Clinical Research Site | Redlands | California | 92374 | — |
| Clinical Research Site | Santa Monica | California | 90404 | — |
| Clinical Research Site | Spring Valley | California | 91978 | — |
| Clinical Research Site | Walnut Creek | California | 94598 | — |
| Clinical Research Site | Hallandale | Florida | 33009 | — |
| Clinical Research Site | Jacksonville | Florida | 32256 | — |
| Clinical Research Site | Lake City | Florida | 32055 | — |
| Clinical Research Site | Lake Worth | Florida | 33467 | — |
| Clinical Research Site | Ocoee | Florida | 34761 | — |
| Clinical Research Site | Orlando | Florida | 32801 | — |
| Clinical Research Site | Ormond Beach | Florida | 32174 | — |
| Clinical Research Site | South Miami | Florida | 33143 | — |
| Clinical Research Site | Sunrise | Florida | 33351 | — |
| Clinical Research Site | Tampa | Florida | 33634 | — |
| Clinical Research Site | Stockbridge | Georgia | 30281 | — |
| Clinical Research Site | Evanston | Illinois | 60201 | — |
| Clinical Research Site | Louisville | Kentucky | 40213 | — |
| Clinical Research Site | Boston | Massachusetts | 02131 | — |
| Clinical Research Site | Waltham | Massachusetts | 02451 | — |
| Clinical Research Site | Ann Arbor | Michigan | 48104 | — |
| Clinical Research Site | Springfield | Missouri | 65810 | — |
| Clinical Research Site | Albuquerque | New Mexico | 87102 | — |
| Clinical Research Site | Manlius | New York | 13104 | — |
| Clinical Research Site | Williamsville | New York | 14221 | — |
| Clinical Research Site | High Point | North Carolina | 27262 | — |
| Clinical Research Site | Oklahoma City | Oklahoma | 73106 | — |
| Clinical Research Site | Philadelphia | Pennsylvania | 19114 | — |
| Clinical Research Site | Charleston | South Carolina | 29406 | — |
| Clinical Research Site | Mt. Pleasant | South Carolina | 29464 | — |
| Clinical Research Site | Memphis | Tennessee | 38119 | — |
| Clinical Research Site | Nashville | Tennessee | 37203 | — |
| Clinical Research Site | Austin | Texas | 78731 | — |
| Clinical Research Site | Salt Lake City | Utah | 84107 | — |
| Clinical Research Site | Charlottesville | Virginia | 22911 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04163185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 28, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04163185 live on ClinicalTrials.gov.